Showing results 2 to 3 of 3
HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer Jung, Kyung Hee; Yan, Hong Hua; Fang, Zhenghuan; Son, Mi Kwon; Lee, Hyunseung; Hong, Sungwoo; Hong, Soon-Sun, INTERNATIONAL JOURNAL OF ONCOLOGY, v.45, no.1, pp.311 - 321, 2014-07 |
Strategies to overcome acquired resistances conferred by mutations in the kinase domain of EGFR Lim, Sang Min; Jeong, Yujeong; Hong, Sungwoo, FUTURE MEDICINAL CHEMISTRY, v.8, no.8, pp.853 - 878, 2016-05 |
Discover